170 related articles for article (PubMed ID: 8549769)
21. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
[TBL] [Abstract][Full Text] [Related]
22. The human chemoattractant complement C5a receptor inhibits cyclic AMP accumulation through Gi and Gz proteins.
Shum JK; Allen RA; Wong YH
Biochem Biophys Res Commun; 1995 Mar; 208(1):223-9. PubMed ID: 7887933
[TBL] [Abstract][Full Text] [Related]
23. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor.
Gao JL; Becker EL; Freer RJ; Muthukumaraswamy N; Murphy PM
J Exp Med; 1994 Dec; 180(6):2191-7. PubMed ID: 7964494
[TBL] [Abstract][Full Text] [Related]
24. A mathematical model for ligand/receptor/G-protein dynamics and actin polymerization in human neutrophils.
Adams JA; Omann GM; Linderman JJ
J Theor Biol; 1998 Aug; 193(4):543-60. PubMed ID: 9745752
[TBL] [Abstract][Full Text] [Related]
25. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
Mery L; Boulay F
J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
[TBL] [Abstract][Full Text] [Related]
26. Mutation of aspartate 82 of the human C5a receptor abolishes the secretory response to human C5a in transfected rat basophilic leukemia cells.
Monk PN; Pease JE; Marland G; Barker MD
Eur J Immunol; 1994 Nov; 24(11):2922-5. PubMed ID: 7957584
[TBL] [Abstract][Full Text] [Related]
27. Specific interactions of chemoattractant factor receptors with G-proteins.
Amatruda TT; Gerard NP; Gerard C; Simon MI
J Biol Chem; 1993 May; 268(14):10139-44. PubMed ID: 8486684
[TBL] [Abstract][Full Text] [Related]
28. Unmasking different constitutive activity of four chemoattractant receptors using Na+ as universal stabilizer of the inactive (R) state.
Seifert R; Wenzel-Seifert K
Recept Channels; 2001; 7(5):357-69. PubMed ID: 11697079
[TBL] [Abstract][Full Text] [Related]
29. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
[TBL] [Abstract][Full Text] [Related]
30. Multiple regions of G alpha 16 contribute to the specificity of activation by the C5a receptor.
Lee CH; Katz A; Simon MI
Mol Pharmacol; 1995 Feb; 47(2):218-23. PubMed ID: 7870028
[TBL] [Abstract][Full Text] [Related]
31. Undifferentiated U937 cells transfected with chemoattractant receptors: a model system to investigate chemotactic mechanisms and receptor structure/function relationships.
Kew RR; Peng T; DiMartino SJ; Madhavan D; Weinman SJ; Cheng D; Prossnitz ER
J Leukoc Biol; 1997 Mar; 61(3):329-37. PubMed ID: 9060456
[TBL] [Abstract][Full Text] [Related]
32. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia.
Lacy M; Jones J; Whittemore SR; Haviland DL; Wetsel RA; Barnum SR
J Neuroimmunol; 1995 Aug; 61(1):71-8. PubMed ID: 7560015
[TBL] [Abstract][Full Text] [Related]
33. Functional reconstitution of a receptor-activated signal transduction pathway in Xenopus laevis oocytes using the cloned human C5a receptor.
Schultz P; Stannek P; Bischoff SC; Dahinden CA; Gierschik P
Cell Signal; 1992 Mar; 4(2):153-61. PubMed ID: 1616822
[TBL] [Abstract][Full Text] [Related]
34. The chemotactic receptor for human C5a anaphylatoxin.
Gerard NP; Gerard C
Nature; 1991 Feb; 349(6310):614-7. PubMed ID: 1847994
[TBL] [Abstract][Full Text] [Related]
35. Multiple activation steps of the N-formyl peptide receptor.
Prossnitz ER; Gilbert TL; Chiang S; Campbell JJ; Qin S; Newman W; Sklar LA; Ye RD
Biochemistry; 1999 Feb; 38(8):2240-7. PubMed ID: 10029516
[TBL] [Abstract][Full Text] [Related]
36. C5a stimulus-secretion coupling in rat basophilic leukaemia (RBL-2H3) cells transfected with the human C5a receptor is mediated by pertussis and cholera toxin-sensitive G proteins.
Monk PN; Pease JE; Barker MD
Biochem Mol Biol Int; 1994 Jan; 32(1):13-20. PubMed ID: 8012277
[TBL] [Abstract][Full Text] [Related]
37. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity.
Richardson RM; Ali H; Tomhave ED; Haribabu B; Snyderman R
J Biol Chem; 1995 Nov; 270(46):27829-33. PubMed ID: 7499254
[TBL] [Abstract][Full Text] [Related]
38. Amino acids 327-350 of the human C5a-receptor are not essential for [125I]C5a binding in COS cells and signal transduction in Xenopus oocytes.
Klos A; Mätje C; Rheinheimer C; Bautsch W; Köhl J; Martin U; Burg M
FEBS Lett; 1994 May; 344(1):79-82. PubMed ID: 8181569
[TBL] [Abstract][Full Text] [Related]
39. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
[TBL] [Abstract][Full Text] [Related]
40. Stabilization of C5a receptor--G-protein interactions through ligand binding.
Wennogle LP; Conder L; Winter C; Braunwalder A; Vlattas S; Kramer R; Cioffi C; Hu SI
J Cell Biochem; 1994 Jul; 55(3):380-8. PubMed ID: 7962171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
